FST and Insulin resistance: Specific outcomes of interest included clinical (e.g., menstrual regularity, ovulation rate, hirsutism), metabolic (e.g., BMI, insulin resistance, hepatic markers), hormonal (e.g., free testosterone, follistatin), and patient-reported outcomes such as quality of life.